Delays associated with manufacturing and supply chain scaleup led Pfizer Inc. and BioNTech SE to lower expectations for their COVID-19 vaccine production in 2020 by half.
The delays are a testament to the challenge of establishing large-scale supply chains and manufacturing processes for urgently needed vaccines...







